Relationship between CCL25/CCR9 Levels in Follicular Fluid and High Ovarian Response in Patients with Polycystic Ovary Syndrome

Relationship between CCL25/CCR9 Levels in Follicular Fluid and High Ovarian Response in Patients with Polycystic Ovary Syndrome

Objective. Polycystic ovary syndrome (PCOS) is one of the prevalent gynecological endocrine disorders encountered in clinical practice. Women diagnosed with PCOS demonstrate increased ovarian responsiveness, rendering them more prone to ovarian hyperstimulation syndrome (OHSS) during controlled ovar...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yongxin Hao, Qianqian Yin, Fangfang Hu, Xiaoyan Liu, Yaru Yang, Fang Sun, Xiaonan Yan
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2024/2449037
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
by: Xu Boqun, et al.
Published: (2013-01-01)

CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson’s disease models
by: Felipe Saceanu Leser, et al.
Published: (2025-02-01)

CCL5 Induces a Sarcopenic-like Phenotype via the CCR5 Receptor
by: Francisco Aguirre, et al.
Published: (2025-01-01)

Progress of CCL20-CCR6 in the airways: a promising new therapeutic target
by: Ya -Jing Li, et al.
Published: (2024-12-01)

Correction: Progress of CCL20-CCR6 in the airways: a promising new therapeutic target
by: Ya -Jing Li, et al.
Published: (2025-01-01)

Diagnosis and treatment of polycystic ovary syndrome
by: Ronelsys Martínez Martínez, et al.
Published: (2023-11-01)

CCR9 Antagonists in the Treatment of Ulcerative Colitis
by: Pirow Bekker, et al.
Published: (2015-01-01)

Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis
by: Ryunosuke Nakagawa, et al.
Published: (2025-02-01)

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
by: Pascal Froment, et al.
Published: (2006-01-01)

Polycystic Ovary Syndrome May Be an Autoimmune Disorder
by: Hifsa Mobeen, et al.
Published: (2016-01-01)

Bariatric Surgery, Polycystic Ovary Syndrome, and Infertility
by: James Butterworth, et al.
Published: (2016-01-01)

Impact of headache in women with polycystic ovary syndrome
by: Lina Zabulienë, et al.
Published: (2021-12-01)

mTOR downregulation promotes anti-inflammatory responses via the CCL3-CCR5 axis in hypoxic retinopathy
by: Tae Kwon Moon, et al.
Published: (2025-03-01)

Relation of Follicular Fluid Soluble Receptor for Advanced Glycation End-Products Concentration and Anti Mullerian Hormone in Polycystic Ovary Syndrome and Non-PCOS Women Referring to In Vitro Fertilization Center: Case-Control Study
by: Neda Emami, et al.
Published: (2025-01-01)

Extended High Frequency Audiometry in Polycystic Ovary Syndrome
by: Cuneyt Kucur, et al.
Published: (2013-01-01)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
by: Thozhukat Sathyapalan, et al.
Published: (2010-01-01)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
by: Carlos Moran, et al.
Published: (2012-01-01)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
by: Sweekruti Jena, et al.
Published: (2023-04-01)

Proximity extension assay revealed novel inflammatory biomarkers for follicular development and ovarian function: a prospective controlled study combining serum and follicular fluid
by: Chong Wang, et al.
Published: (2025-02-01)

Oxidative Stress in Endometrial Flushing Fluid of Patients with Polycystic Ovary Syndrome, Endometrioma and Uterine Leiomyoma: Comparison with Healthy Controls
by: Mustafa Demir, et al.
Published: (2020-08-01)

Mastalgia Assesment and Hormonal Correlations in Patients with Polycystic Ovary Syndrome
by: Emel Kıyak Çağlayan, et al.
Published: (2015-04-01)

The Prevalence of Polycystic Ovary Syndrome in Women with Idiopathic Intracranial Hypertension
by: Inbal Avisar, et al.
Published: (2012-01-01)

Proposal for an Educational Program for the Prevention of Complications of Polycystic Ovary Syndrome
by: Edison Sotalin Nivela, et al.
Published: (2024-01-01)

Health-related Quality of Life in Women with Polycystic Ovary Syndrome
by: Belén Carazo Hernández, et al.
Published: (2014-04-01)

Ovulation Induction Techniques in Polycystic Ovary Syndrome - Systematic Review
by: Daria Michałka, et al.
Published: (2025-01-01)

Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01)

The role of immunity in insulin resistance in patients with polycystic ovary syndrome
by: Qixuan Zhang, et al.
Published: (2025-01-01)

Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome
by: WANG Xueling, et al.
Published: (2025-02-01)

Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome
by: Armaiti Parvez Mody, et al.
Published: (2025-01-01)

Evaluation of Retinal Changes in Women with Different Phenotypes of Polycystic Ovary Syndrome
by: Fatma Sumer, et al.
Published: (2025-01-01)

Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway
by: Chenye Wang, et al.
Published: (2020-01-01)

Serum Zinc Levels in Women with Polycystic Ovarian Syndrome are Lower as Compared to Those without Polycystic Ovarian Syndrome: A Cohort Study
by: Swati Dhar, et al.
Published: (2024-01-01)

Therapeutic role of isoflavones from traditional medicine in the management of polycystic ovary syndrome
by: Ashwini Armarkar, et al.
Published: (2025-03-01)

Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome
by: Alexandre Connolly, et al.
Published: (2018-01-01)

Does Polycystic Ovary Syndrome Itself Have Additional Effect on Apelin Levels?
by: Dilek Benk Silfeler, et al.
Published: (2014-01-01)

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
by: Zhuo Liu, et al.
Published: (2025-01-01)

Prevalence Of Skin Manifestations In Patients With Polycystic Ovarian Syndrome
by: Tehseen Naveed, et al.
Published: (2024-03-01)

From Placenta to Polycystic Ovarian Syndrome: The Role of Adipokines
by: Chiara Sartori, et al.
Published: (2016-01-01)

Ovarian Follicular Dynamics during the Estrous Cycle in Jennies in Upper Egypt
by: R. I. Derar, et al.
Published: (2011-01-01)

Ocular Surface Disease Severity in Polycystic Ovary Syndrome: is This Really Significant in Daily Life?
by: Demet Yabanoglu, et al.
Published: (2022-03-01)